| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |